Latest Long acting beta-adrenoceptor agonist Stories
The COPD Market Will Fracture with the Continuing Entry of LABA/LAMAs and Other Later-to-Market Bronchodilators, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
RIDGEFIELD, Conn., Oct.
LifeScienceIndustryResearch.com adds “Pulmicort (Asthma) – Forecast and Market Analysis to 2023” to its store.
LifeScienceIndustryResearch.com adds “Symbicort (Asthma) - Forecast and Market Analysis to 2023” to its store.
-- LANTERN study met primary endpoint demonstrating non-inferiority of Ultibro® Breezhaler® 110/50 mcg vs Advair* Diskus* (SFC) 50/500 mcg followed by statistically
For U.S. Media Only RIDGEFIELD, Conn., Aug. 19, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S.
For U.S. Media Only RIDGEFIELD, Conn., Aug. 1, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S.
LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
BURLINGTON, ON, June 19, 2014 /CNW/ - Results from a Phase III 52 week study, show tiotropium (delivered via Respimat(®)*)5µg, a once-daily long-acting anticholinergic bronchodilator, is efficacious
OXFORD, England, May 15, 2014 /PRNewswire/ -- First full presentation of data from randomised clinical study of glycopyrronium bromide made using
- A trick or prank.